MIT Media Lab's E14 fund has contributed to a round that will fund research and development for the logistics management platform developer.

Rutgers University-New Brunswick has spun out Infinity Biologix with backing from Viking Global Investors to manage the distribution of a saliva-based coronavirus test.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Big data analysis provider Palantir has followed a $50m investment by Fujitsu with $500m from its partner in a Japanese joint venture.

The Novartis and Eli Lilly-backed cancer and haematologic disease drug developer will go public today having expanded the size of its offering.

The targeted oncology drug developer, which counts Bristol Myers Squibb and Celgene as investors, is floating above its range in an upsized offering.

Kaiser Permanente contributed to a round that pushed the total raised by the ceullar cancer therapy developer to $300m.

The oil and gas producer’s Wind Ventures vehicle features ex-corporate venturers from Konica Minolta and GM Ventures, and has revealed its first portfolio companies.

Comcast Ventures returned for a $35.1m round for the financial planning service that took place two years after it emerged from stealth.

The healthcare data integrator boosted its overall funding to $53m in a series B round led by Blue Venture Fund that included Echo Health Ventures.